24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Oleoylethanolamide Modulates BDNF-ERK Signaling and Neurogenesis in the Hippocampi of Rats Exposed to Δ 9-THC and Ethanol Binge Drinking During Adolescence

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Oleoylethanolamide is an endogenous NAE that modulates ethanol-seeking behavior and ethanol-induced neuroinflammation. In the present study we further analyze the role of OEA in hippocampal neurogenesis, BDNF-ERK signaling, and spatial memory that are affected by alcohol. Additionally, we addressed the effects of OEA on the association of alcohol and cannabis, a frequent combination in human alcohol addicts, and whose long-term effects are far from being understood. To this end, OEA (10 mg/kg/day, i.p.) was pharmacologically administered for 5 days/week in a preclinical model of adolescent rats with binge-like consumption (1 day/week) of ethanol (3 g/kg, i.g.) combined or not with acute administrations of Δ 9-THC (5 mg/kg, i.p.) for 5 weeks. OEA restored ethanol/THC-related decreases in both short-term spatial memory (spontaneous alternation by Y-maze) and circulating levels of BDNF, reduced cell proliferation ( Mki67 and IdU+ cells) and maturation ( Dcx, Calb1), and improved cell survival ( Casp3 and BrdU+ cells) in the dorsal hippocampus. Interestingly, OEA alone or combined with THC also decreased the mRNA levels of neurotrophic factors ( Bdnf, Ntf3) and the NT3 receptor TrkC, but increased the BDNF receptor TrkB in the hippocampus of ethanol-exposed rats. These effects were likely associated with a OEA-specific phosphorylation of AKT and ERK1, key signaling regulators of cell proliferation and survival. These results suggest a regulatory role of OEA in short-term spatial memory and hippocampal neurogenesis through BDNF/AKT/ERK1 signaling in response to acute THC in an alcoholic context during adolescence.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          The endogenous cannabinoid system controls extinction of aversive memories.

          Acquisition and storage of aversive memories is one of the basic principles of central nervous systems throughout the animal kingdom. In the absence of reinforcement, the resulting behavioural response will gradually diminish to be finally extinct. Despite the importance of extinction, its cellular mechanisms are largely unknown. The cannabinoid receptor 1 (CB1) and endocannabinoids are present in memory-related brain areas and modulate memory. Here we show that the endogenous cannabinoid system has a central function in extinction of aversive memories. CB1-deficient mice showed strongly impaired short-term and long-term extinction in auditory fear-conditioning tests, with unaffected memory acquisition and consolidation. Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction. Consistently, tone presentation during extinction trials resulted in elevated levels of endocannabinoids in the basolateral amygdala complex, a region known to control extinction of aversive memories. In the basolateral amygdala, endocannabinoids and CB1 were crucially involved in long-term depression of GABA (gamma-aminobutyric acid)-mediated inhibitory currents. We propose that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

            Endogenous neuromodulatory molecules are commonly coupled to specific metabolic enzymes to ensure rapid signal inactivation. Thus, acetylcholine is hydrolysed by acetylcholine esterase and tryptamine neurotransmitters like serotonin are degraded by monoamine oxidases. Previously, we reported the structure and sleep-inducing properties of cis-9-octadecenamide, a lipid isolated from the cerebrospinal fluid of sleep-deprived cats. cis-9-Octadecenamide, or oleamide, has since been shown to affect serotonergic systems and block gap-junction communication in glial cells (our unpublished results). We also identified a membrane-bound enzyme activity that hydrolyses oleamide to its inactive acid, oleic acid. We now report the mechanism-based isolation, cloning and expression of this enzyme activity, originally named oleamide hydrolase, from rat liver plasma membranes. We also show that oleamide hydrolase converts anandamide, a fatty-acid amide identified as the endogenous ligand for the cannabinoid receptor, to arachidonic acid, indicating that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling molecules, the fatty-acid amides. Therefore we will hereafter refer to oleamide hydrolase as fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amides that the enzyme can accept as substrates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cannabis and the brain.

              The active compound in herbal cannabis, Delta(9)-tetrahydrocannabinol, exerts all of its known central effects through the CB(1) cannabinoid receptor. Research on cannabinoid mechanisms has been facilitated by the availability of selective antagonists acting at CB(1) receptors and the generation of CB(1) receptor knockout mice. Particularly important classes of neurons that express high levels of CB(1) receptors are GABAergic interneurons in hippocampus, amygdala and cerebral cortex, which also contain the neuropeptides cholecystokinin. Activation of CB(1) receptors leads to inhibition of the release of amino acid and monoamine neurotransmitters. The lipid derivatives anandamide and 2-arachidonylglycerol act as endogenous ligands for CB(1) receptors (endocannabinoids). They may act as retrograde synaptic mediators of the phenomena of depolarization-induced suppression of inhibition or excitation in hippocampus and cerebellum. Central effects of cannabinoids include disruption of psychomotor behaviour, short-term memory impairment, intoxication, stimulation of appetite, antinociceptive actions (particularly against pain of neuropathic origin) and anti-emetic effects. Although there are signs of mild cognitive impairment in chronic cannabis users there is little evidence that such impairments are irreversible, or that they are accompanied by drug-induced neuropathology. A proportion of regular users of cannabis develop tolerance and dependence on the drug. Some studies have linked chronic use of cannabis with an increased risk of psychiatric illness, but there is little evidence for any causal link. The potential medical applications of cannabis in the treatment of painful muscle spasms and other symptoms of multiple sclerosis are currently being tested in clinical trials. Medicines based on drugs that enhance the function of endocannabinoids may offer novel therapeutic approaches in the future.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Mol Neurosci
                Front Mol Neurosci
                Front. Mol. Neurosci.
                Frontiers in Molecular Neuroscience
                Frontiers Media S.A.
                1662-5099
                24 April 2019
                2019
                : 12
                : 96
                Affiliations
                [1] 1Instituto de Investigación Biomédica de Málaga, U.G.C. de Salud Mental, Hospital Regional Universitario de Málaga , Málaga, Spain
                [2] 2Department of Endocrinology, Fundación Investigación Biomédica del Hospital Infantil Universitario Niño Jesús , Madrid, Spain
                [3] 3Departamento de Psicobiología, Universidad Complutense Madrid , Pozuelo de Alarcón, Spain
                [4] 4Departamento de Anatomía y Medicina Legal, Universidad de Málaga , Málaga, Spain
                Author notes

                Edited by: Eric Murillo-Rodriguez, Anahuac Mayab University, Mexico

                Reviewed by: Ricardo Marcos Pautassi, National Scientific and Technological Research Council (CONICET), Argentina; Olga Valverde, Pompeu Fabra University, Spain

                *Correspondence: Fernando Rodríguez de Fonseca, fernando.rodriguez@ 123456ibima.eu Juan Suárez, juan.suarez@ 123456ibima.eu
                Article
                10.3389/fnmol.2019.00096
                6491684
                31068789
                4daaf091-f2cf-4707-a4e4-a6e213176ab8
                Copyright © 2019 Silva-Peña, Rivera, Alén, Vargas, Rubio, García-Marchena, Pavón, Serrano, Rodríguez de Fonseca and Suárez.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 11 December 2018
                : 01 April 2019
                Page count
                Figures: 8, Tables: 0, Equations: 0, References: 66, Pages: 15, Words: 0
                Funding
                Funded by: Instituto de Salud Carlos III 10.13039/501100004587
                Award ID: RD16/0017/0001
                Award ID: PI16/01374
                Award ID: PI16/01698
                Award ID: PI16/01953
                Award ID: PI17/02026
                Award ID: CP14/00212
                Award ID: CP14/00173
                Award ID: CPII17/00024
                Award ID: CD16/00067
                Funded by: Ministerio de Sanidad, Servicios Sociales e Igualdad 10.13039/501100003751
                Award ID: PNSD2015/047
                Award ID: PND2017/043
                Funded by: Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía 10.13039/501100002878
                Funded by: Consejería de Salud, Junta de Andalucía 10.13039/501100010566
                Categories
                Neuroscience
                Original Research

                Neurosciences
                alcohol,brain-derived neurotrophic factor,erk,hippocampus,memory,oleoylethanolamide
                Neurosciences
                alcohol, brain-derived neurotrophic factor, erk, hippocampus, memory, oleoylethanolamide

                Comments

                Comment on this article